| 000 | 01657 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513094723.0 | ||
| 264 | 0 | _c19961023 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(95)00604-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobineau, P | |
| 245 | 0 | 0 |
_aIn vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cDec 1995 |
||
| 300 |
_a677-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBronchoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 |
_aCell Degranulation _xdrug effects |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 | _aNeurokinin-1 Receptor Antagonists |
| 650 | 0 | 4 |
_aOligopeptides _xmetabolism |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSalivation _xdrug effects |
| 650 | 0 | 4 |
_aSubstance P _xpharmacology |
| 700 | 1 | _aLonchampt, M | |
| 700 | 1 | _aKucharczyk, N | |
| 700 | 1 | _aKrause, J E | |
| 700 | 1 | _aRegoli, D | |
| 700 | 1 | _aFauchere, J L | |
| 700 | 1 | _aProst, J F | |
| 700 | 1 | _aCanet, E | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 294 _gno. 2-3 _gp. 677-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(95)00604-4 _zAvailable from publisher's website |
| 999 |
_c8747736 _d8747736 |
||